Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dietlein

Showing results (61-70 of 126) with videos related to

Pageof 13
Sort By:
Nuklearmedizin. Nuclear Medicine|September 30, 2010
Recombinant human TSH versus hypothyroidism. Cost-minimization-analysis in the follow-up care of differentiated thyroid carcinomaM Dietlein, S Busemeyer, C Kobe, et al.
NMR in Biomedicine|February 11, 2000
Systemic alterations in phospholipid concentrations of blood plasma in patients with thyroid carcinoma: an in-vitro (31)P high-resolution NMR studyK Raffelt, D Moka, F Süllentrop, et al.
Nuklearmedizin. Nuclear Medicine|October 17, 2007
[Procedure guideline for thyroid scintigraphy (version 3)]M Dietlein, J Dressler, W Eschner, et al.
Rontgen-Blatter; Zeitschrift Fur Rontgen-Technik Und Medizinisch-Wissenschaftliche Photographie|May 1, 1990
[Assessment of the grading of cartilaginous tumors of the long tubular bones from the radiologic and pathologic viewpoint]M Dietlein, W Féaux de Lacroix, K F Neufang, et al.
Nuklearmedizin. Nuclear Medicine|April 9, 2008
[Routine measurement of serum calcitonin in patients with nodular thyroid disorders?]M Dietlein, H Wieler, M Schmidt, et al.
European Journal of Endocrinology|August 18, 2006
Cost-effectiveness of using recombinant human TSH prior to radioiodine ablation for thyroid cancer, compared with treating patients in a hypothyroid state: the German perspectiveP Mernagh, S Campbell, M Dietlein, et al.
European Journal of Nuclear Medicine|June 15, 2000
Iterative reconstruction: an improvement of technetium-99m MIBI SPET for the detection of parathyroid adenomas?D Moka, W Eschner, E Voth, et al.
Nuklearmedizin. Nuclear Medicine|October 15, 2008
[Obesity, energy regulation and thyroid function: is borderline elevated TSH-level the cause or secondary phenomenon of obesity]M Dietlein, G Kahaly, C Kobe, et al.
Nuklearmedizin. Nuclear Medicine|February 13, 1999
[Cost-effectiveness analysis: radioiodine or antithyroid medication in primary treatment of immune hyperthyroidism]M Dietlein, D Moka, B Dederichs, et al.
Nuklearmedizin. Nuclear Medicine|June 6, 2007
Administration of additional inactive iodide during radioiodine therapy for Graves' disease: who might benefit?M Dietlein, D Moka, U Reinholz, et al.
Pageof 13

Showing results (61-70 of 126) with videos related to

Sort By:
Pageof 13
Nuklearmedizin. Nuclear Medicine|September 30, 2010
Recombinant human TSH versus hypothyroidism. Cost-minimization-analysis in the follow-up care of differentiated thyroid carcinomaM Dietlein, S Busemeyer, C Kobe, et al.
NMR in Biomedicine|February 11, 2000
Systemic alterations in phospholipid concentrations of blood plasma in patients with thyroid carcinoma: an in-vitro (31)P high-resolution NMR studyK Raffelt, D Moka, F Süllentrop, et al.
Nuklearmedizin. Nuclear Medicine|October 17, 2007
[Procedure guideline for thyroid scintigraphy (version 3)]M Dietlein, J Dressler, W Eschner, et al.
Rontgen-Blatter; Zeitschrift Fur Rontgen-Technik Und Medizinisch-Wissenschaftliche Photographie|May 1, 1990
[Assessment of the grading of cartilaginous tumors of the long tubular bones from the radiologic and pathologic viewpoint]M Dietlein, W Féaux de Lacroix, K F Neufang, et al.
Nuklearmedizin. Nuclear Medicine|April 9, 2008
[Routine measurement of serum calcitonin in patients with nodular thyroid disorders?]M Dietlein, H Wieler, M Schmidt, et al.
European Journal of Endocrinology|August 18, 2006
Cost-effectiveness of using recombinant human TSH prior to radioiodine ablation for thyroid cancer, compared with treating patients in a hypothyroid state: the German perspectiveP Mernagh, S Campbell, M Dietlein, et al.
European Journal of Nuclear Medicine|June 15, 2000
Iterative reconstruction: an improvement of technetium-99m MIBI SPET for the detection of parathyroid adenomas?D Moka, W Eschner, E Voth, et al.
Nuklearmedizin. Nuclear Medicine|October 15, 2008
[Obesity, energy regulation and thyroid function: is borderline elevated TSH-level the cause or secondary phenomenon of obesity]M Dietlein, G Kahaly, C Kobe, et al.
Nuklearmedizin. Nuclear Medicine|February 13, 1999
[Cost-effectiveness analysis: radioiodine or antithyroid medication in primary treatment of immune hyperthyroidism]M Dietlein, D Moka, B Dederichs, et al.
Nuklearmedizin. Nuclear Medicine|June 6, 2007
Administration of additional inactive iodide during radioiodine therapy for Graves' disease: who might benefit?M Dietlein, D Moka, U Reinholz, et al.
Pageof 13